The role of cirrhosis in the etiology of hepatocellular carcinoma
- PMID: 24203525
- DOI: 10.1007/s12029-013-9556-9
The role of cirrhosis in the etiology of hepatocellular carcinoma
Abstract
Abundant evidence supports the belief of a causal relationship between cirrhosis and hepatocellular carcinoma, but one that differs between high- and low-incidence regions of the tumor. In high-incidence regions, the cirrhosis is of the macronodular variety, is typically asymptomatic, and is caused predominantly by chronic hepatitis B virus infection, whereas in low-incidence regions, the cirrhosis, although usually macronodular, may be micronodular, is commonly symptomatic and of long-standing, and is caused by chronic hepatitis C virus infection, alcohol abuse over many years, the metabolic syndrome, or hereditary hemochromatosis. In a minority of patients, hepatocellular carcinoma develops in the absence of cirrhosis, supporting a direct hepatocarcinogenic effect of some of the causal agents. Cirrhosis is the major risk factor for tumor formation in patients with chronic hepatitis C virus infection. This virus does not integrate into cellular DNA, and malignant transformation results from increased liver cell turnover induced by recurring injury and regeneration of cells in the context of persisting inflammation, oxidative DNA damage, fibrosis, cirrhosis, and changes induced by the virus at a DNA level that have yet to be fully defined. Hepatitis B virus causes malignant transformation by both direct and indirect routes. The direct route results, in part, from integration of the viral DNA into host cellular DNA; transcriptional activation of host growth regulatory genes by hepatitis B virus-encoded proteins; and effects on apoptosis, cell signaling, and DNA repair. The direct route may share some similarities with that of hepatitis C virus infection. The metabolic syndrome may cause malignant transformation by production of oxidative stress and the induction of a variety of mutations, including some in the p53 gene.
Similar articles
-
HCV-associated hepatocellular carcinoma without cirrhosis.J Hepatol. 1996 Mar;24(3):277-85. doi: 10.1016/s0168-8278(96)80005-5. J Hepatol. 1996. PMID: 8778193
-
[Epidemiology, natural history and pathogenesis of hepatocellular carcinoma].Cancer Radiother. 2011 Feb;15(1):3-6. doi: 10.1016/j.canrad.2010.11.010. Epub 2011 Jan 15. Cancer Radiother. 2011. PMID: 21239205 Review. French.
-
Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.Ann Intern Med. 1992 Jan 15;116(2):97-102. doi: 10.7326/0003-4819-116-2-97. Ann Intern Med. 1992. PMID: 1309286
-
Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma.J Med Virol. 1990 May;31(1):18-32. doi: 10.1002/jmv.1890310106. J Med Virol. 1990. PMID: 2165515 Review.
-
Hepatocellular carcinoma in cirrhosis: incidence and risk factors.Gastroenterology. 2004 Nov;127(5 Suppl 1):S35-50. doi: 10.1053/j.gastro.2004.09.014. Gastroenterology. 2004. PMID: 15508101 Review.
Cited by
-
Effects of recombinant human adenovirus-p53 on the regression of hepatic fibrosis.Int J Mol Med. 2016 Oct;38(4):1093-100. doi: 10.3892/ijmm.2016.2716. Epub 2016 Aug 26. Int J Mol Med. 2016. PMID: 27572658 Free PMC article.
-
Ambiguous roles of innate lymphoid cells in chronic development of liver diseases.World J Gastroenterol. 2018 May 14;24(18):1962-1977. doi: 10.3748/wjg.v24.i18.1962. World J Gastroenterol. 2018. PMID: 29760540 Free PMC article. Review.
-
Inhibition of diethylnitrosamine-initiated alcohol-promoted hepatic inflammation and precancerous lesions by flavonoid luteolin is associated with increased sirtuin 1 activity in mice.Hepatobiliary Surg Nutr. 2015 Apr;4(2):124-34. doi: 10.3978/j.issn.2304-3881.2014.08.06. Hepatobiliary Surg Nutr. 2015. PMID: 26005679 Free PMC article.
-
Liver stiffness measurement predicted liver-related events and all-cause mortality: A systematic review and nonlinear dose-response meta-analysis.Hepatol Commun. 2018 Feb 13;2(4):467-476. doi: 10.1002/hep4.1154. eCollection 2018 Apr. Hepatol Commun. 2018. Retraction in: Hepatol Commun. 2024 May 2;8(5):e0463. doi: 10.1097/HC9.0000000000000463 PMID: 29619424 Free PMC article. Retracted.
-
MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?Cancers (Basel). 2023 Nov 23;15(23):5557. doi: 10.3390/cancers15235557. Cancers (Basel). 2023. PMID: 38067261 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous